ORGANIC
LETTERS
2003
Vol. 5, No. 22
4053-4055
Concise Synthesis of the
Chemopreventitive Agent (±)-Deguelin
via a Key 6-Endo Hydroarylation
Stefan J. Pastine and Dalibor Sames*
Department of Chemistry, Columbia UniVersity, New York, New York 10027
Received July 28, 2003
ABSTRACT
A concise total synthesis of (±)-deguelin was achieved with a longest linear sequence of six steps in 68% yield. A key step was the platinum-
catalyzed 6-endo hydroarylation of an alkynone intermediate.
In part of a broad program focused on C-H bond function-
alization, we became interested in C-H to C-C bond
transformations at the arene nucleus.1 In this context, we have
centered our attention on intramolecular hydroarylation
methodology, which would provide a direct route to various
carbocyclic and heterocyclic compounds. Specifically, a
structural search identified chromenes and coumarins as
particularly attractive targets due to their frequent occurrence
in biologically relevant natural products. Consequently, we
have developed a new platinum-catalyzed hydroarylation
method that provides direct access to chromene and coumarin
scaffolds from arene-yne substrates.2
skin and mammary tumerogenesis,3 inhibited the growth of
and induced apoptosis in premalignant and malignant human
bronchial epithelial (HBE) cells with minimal effects on
normal HBE cells,4 and suppressed colonic preneoplastic
lesions in Cf-1 mice.5 Its activity has been linked to its potent
inhibition of ornithine decarboxylase activity; in contrast to
other members of the rotenoid family, deguelin does not
inhibit microtubular assembly or tubulin polymerization.6
Previous synthetic efforts toward the rotenoid class,
including two total syntheses of 1,7 have been lengthy and
inefficient,8 and thus a general solution for the synthesis of
this class of compounds has not yet been realized. To obtain
We set out to address the question of whether our
hydroarylation method would be applicable to substrates of
high complexity such as those leading to the rotenoid class
of natural products. Specifically, we were interested in
synthesizing deguelin 1, which has recently received con-
siderable attention for its promising pharmacological proper-
ties. Deguelin has been shown to be an efficacious chemo-
preventitive agent for both in vitro and in vivo models. For
example, it has exhibited chemopreventitive effects in both
(3) Undeani, G. O.; Gerhauser, C. Thomas, C. F.; Moon, R. C.;
Kosmeder, J. W.; Kinghorn, A. D.; Moriarty, R. M.; Pezzuto, J. M. Cancer
Res. 1997, 57, 3424-3428.
(4) Chun, K. H.; Kosmeder, J. W, Sun, S.; Pezzuto, J. M.; Lotan, R.;
Hong, W. K.; Lee, Y. H. J. Natl. Cancer Inst. 2003, 95, 291-302.
(5) (a) Murillo, G.; Salti, G. I.; Kosmeder, J. W.; Pezzuto, J. M.; Mehta,
R. G. Eur. J. Cancer 2002, 38, 2446-2454. (b) Murillo, G.; Kosmeder, J.
W.; Pezzuto, J. M.; Mehta, R. G. Int. J. Cancer 2003, 104, 7-11.
(6) (a) Gerhauser, C.; Lee, S. K.; Kosmeder, J. W.; Moriarty, R. M.;
Hamal, E.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer Res. 1997,
57, 3429-3435. (b) Casida, J. E.; Fang, N. Proc. Natl. Acad. Sci. U.S.A.
1998, 95, 3380-3384.
(1) Sezen, B.; Sames. D. J. Am. Chem. Soc. 2003, 125, 5274-5275.
(2) (a) Pastine, S. J.; Youn, S. W.; Sames, D. Org. Lett. 2003, 5, 1055-
1058. (b) Pastine, S. J.; Youn, S. W.; Sames, D. Tetrahedron 2003, ASAP.
(7) (a) Omokawa, H.; Yamashita, K. Agr. Biol. Chem. 1974, 38, 1731-
1734. (b) Fukami, H.; Oda, J.; Sakata, G.; Nakajima, M. Agr. Biol. Chem.
1961, 25, 252-256.
10.1021/ol035419j CCC: $25.00 © 2003 American Chemical Society
Published on Web 09/26/2003